CR10518A - Nuevos analogos del peptido intestinal vasoactivo - Google Patents

Nuevos analogos del peptido intestinal vasoactivo

Info

Publication number
CR10518A
CR10518A CR10518A CR10518A CR10518A CR 10518 A CR10518 A CR 10518A CR 10518 A CR10518 A CR 10518A CR 10518 A CR10518 A CR 10518A CR 10518 A CR10518 A CR 10518A
Authority
CR
Costa Rica
Prior art keywords
vasoactive intestinal
intestinal peptide
new analogs
analogs
new
Prior art date
Application number
CR10518A
Other languages
English (en)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10518(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR10518A publication Critical patent/CR10518A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un agonista del receptor VPAC-2 de formula [X-(Id. de Sec. N°:2)-Y] para el tratamiento de las enfermedades obstructivas pulmonares, por ejemplo la EPOC, administrado, por ejemplo, por inhalacion.
CR10518A 2006-07-06 2008-12-17 Nuevos analogos del peptido intestinal vasoactivo CR10518A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06

Publications (1)

Publication Number Publication Date
CR10518A true CR10518A (es) 2009-01-27

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10518A CR10518A (es) 2006-07-06 2008-12-17 Nuevos analogos del peptido intestinal vasoactivo

Country Status (20)

Country Link
US (1) US20080096807A1 (es)
EP (1) EP2041168A2 (es)
JP (1) JP2009542593A (es)
KR (1) KR20090027239A (es)
CN (1) CN101484468A (es)
AR (1) AR061825A1 (es)
AU (1) AU2007271274A1 (es)
BR (1) BRPI0714306A2 (es)
CA (1) CA2656757A1 (es)
CL (1) CL2007001956A1 (es)
CR (1) CR10518A (es)
EC (1) ECSP099029A (es)
IL (1) IL196122A0 (es)
MA (1) MA30590B1 (es)
MX (1) MX2009000013A (es)
NO (1) NO20090027L (es)
PE (1) PE20081000A1 (es)
RU (1) RU2009103811A (es)
TW (1) TW200819139A (es)
WO (1) WO2008003612A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012151296A (ru) 2010-04-30 2014-06-10 Санва Кагаку Кенкюсо Ко., Лтд Пептид для улучшения биостабильности биоактивного вещества и биоактивное вещество, имеющее повышенную биостабильность
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
WO2014145718A2 (en) * 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
ES2818824T3 (es) * 2014-05-08 2021-04-14 Phasebio Pharmaceuticals Inc Composiciones que comprenden una proteína de fusión de VIP-ELP para su uso en el tratamiento de fibrosis quística
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
ATE328004T1 (de) * 1996-02-09 2006-06-15 Hoffmann La Roche Herstellung eines vip-analogen
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
WO2006023358A1 (en) * 2004-08-18 2006-03-02 Eli Lilly And Company Selective vpac2 receptor peptide agonists
JP2008515437A (ja) * 2004-10-08 2008-05-15 フォーブス メディ−テック（リサーチ） インコーポレーテッド 血管活性腸管ポリペプチド医薬品

Also Published As

Publication number Publication date
US20080096807A1 (en) 2008-04-24
NO20090027L (no) 2009-01-15
CN101484468A (zh) 2009-07-15
MX2009000013A (es) 2009-01-23
WO2008003612A3 (en) 2008-02-28
JP2009542593A (ja) 2009-12-03
CL2007001956A1 (es) 2008-04-18
AR061825A1 (es) 2008-09-24
PE20081000A1 (es) 2008-08-06
CA2656757A1 (en) 2008-01-10
ECSP099029A (es) 2009-02-27
IL196122A0 (en) 2011-08-01
BRPI0714306A2 (pt) 2014-05-20
TW200819139A (en) 2008-05-01
WO2008003612A2 (en) 2008-01-10
AU2007271274A1 (en) 2008-01-10
RU2009103811A (ru) 2010-08-20
KR20090027239A (ko) 2009-03-16
EP2041168A2 (en) 2009-04-01
MA30590B1 (fr) 2009-07-01

Similar Documents

Publication Publication Date Title
CR10518A (es) Nuevos analogos del peptido intestinal vasoactivo
MX2021015328A (es) Agonistas del receptor del peptido-1 similar al glucagon.
CY1121853T1 (el) Συνδυαστικη θεραπεια για την αγωγη του διαβητη
MY161450A (en) Double-acylated glp-1 derivatives
CY1115873T1 (el) Νεοι ανταγωνιστες υποδοχεα ccr2 και χρησεις αυτων
BR112012014475A8 (pt) derivados de glp-1 duplo-acilados.
PE20220938A1 (es) Compuestos agonistas de gipr
ECSP088628A (es) Moduladores de receptores cannabinoides
MX2009013138A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
WO2008149147A3 (en) Polypeptides, antibody variable domains and antagonists
CL2008001593A1 (es) Compuestos derivados de heterociclos, antagonistas para el ccr2; y uso de los compuestos para tratar afecciones o enfermedades del tracto respiratorio, como enfermedad pulmonar obstructiva cronica y asma.
WO2010149578A3 (en) Novel biphenyl and phenyl-pyridine amides
TW200833682A (en) Pharmaceutical compounds
MX2010003948A (es) N-fenil-birrolidin ureas sustituidas y uso terapeutico de las mismas.
ATE399770T1 (de) Tachykininrezeptorantagonisten
NO20091058L (no) Sulfonamidforbindelse eller salt derav
TW200806291A (en) Pharmaceutical formulations
WO2008041133A3 (en) Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases
ECSP11011337A (es) 5- (2-{ [6- (2, 2-difluoro-2-feniletoxi) hexil] amino} -1-hidroxietil) -8-hidroxiquinolin-2 (ih)-ona y su uso en el tratamiento de enfermedades pulmonares.
NO20080552L (no) GLP-1 farmasoytiske sammensetninger
ZA202208085B (en) Therapeutic use of long-acting conjugate of triple agonist having activity with respect to all of glucagon and glp-1 and gip receptors against lung disease
PH12021551243A1 (en) Oxyntomodulin peptide analog formulations
AR068439A1 (es) Derivado de 6-pirimidinil-pirimid-2-ona
WO2016033432A9 (en) Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2008041134A3 (en) Use of chlorine guanabenz derivatives for treating prion-based diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)